Paper - WANFANG MED ONLINE

You Position: Home > Paper

Cutaneous Manifestations and Advances in the Treatment of Graft-versus-host Disease

( views:149, downloads:107 )

Author:: No author available

Journal Title:: INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY

Issue:: 3

DOI:: 10.3760/cma.j.issn.1673-4173.2006.03.008

Key Word:: 移植物抗宿主病;疹;光疗

Abstract：移植物抗宿主病是常见于异基因造血干细胞移植术后的一种累及多器官的免疫性疾病.随着移植术广泛开展,有效防治本病成为研究热点.移植物抗宿主病主要出现在病程早期皮肤表现损害多样化.系统应用糖皮质激素为传统一线疗法,但长期用糖皮质激素会引起多种严重的不良反应,因此,各种新的治疗措施研究引起普遍关注.

Reference

[1]Foss F M,DiVenuti G M,Chin K,etc.Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors[J].2005,35(12).
[2]Vincent T, Ho,David, Zahrieh,Ephraim, Hochberg,etc.Safety and efficacy of denileukin diftitox in patients with steroid-refractory acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.[J].2004,104.
[3]Elad S,Or R,Resnick I,etc.Topical tacrolimus--a novel treatment alternative for cutaneous chronic graft-versus-host disease.[J].2003,16(9).
[4]Gurman G,Sanli H,Oskay T,etc.Evaluation of nail involvement in patients with chronic cutaneous graft versus host disease: A single-center study from Turkey.[J].2004,43(3).
[5]Garban F,Drillat P,Makowski C,etc.Extracorporeal chemophototherapy for the treatment of graft-versus-host disease: hematologic consequences of short-term, intensive courses.[J].2005,90(8).
[6]Marijke R, Canninga-van Dijk,Hanneke M, van der Straaten,Rob, Fijnheer,etc.Anti-CD20 monoclonal antibody treatment in 6 patients with therapy-refractory chronic graft-versus-host disease.[J].2004,104.
[7]Wolff D,Roessler V,Steiner B,etc.Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept[J].2005,35(10).
[8]Sanchez AR,Sheridan PJ,Rogers RS.Successful treatment of oral lichen planus-like chronic graft-versus-host disease with topical tacrolimus: a case report.[J].2004,75(4).
[9]Mirjana Ziemer,Jens J Thiele,Bernd Gruhn,etc.Chronic cutaneous graft-versus-host disease in two children responds to UVA1 therapy: Improvement of skin lesions, joint mobility, and quality of life[J].2004,51(2).
[10]ZIEMER M.Treatment of extensive chronic cutaneous graft-versus-host disease in an infant with topical pimecrolimus*1[J].2004.
[11]Wolff D,Horn T,Morison WL,etc.Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease.[J].2004,20(4).
[12]Anasetti C,Carpenter PA,Appelbaum F,etc.A Phase II Multicenter Study of Visilizumab, Humanized Anti-CD3 Antibody, to Treat Steroid-Refractory Acute Graft-versus-Host Disease.[J].2005,11(6).
[13]Pablo F, Pe?as,María, Jones-Caballero,Maximiliano, Aragüés,etc.Sclerodermatous graft-vs-host disease: clinical and pathological study of 17 patients.[J].2002,138.
[14]Wetzig T,Sticherling M,Simon J-C,etc.Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin[J].2005,35(5).
[15]Herzinger T,Berking C,Brenner M,etc.Phototherapy and photochemotherapy of sclerosing skin diseases.[J].2005,21(3).
[16]Francesca, Patriarca,Alessandra, Sperotto,Daniela, Damiani,etc.Infliximab treatment for steroid-refractory acute graft-versus-host disease.[J].2004,89.
[17]Vogelsang GB,Jacobsohn DA,Lucas DM,etc.Pentostatin in steroid-refractory acute graft-versus-host disease.[J].2005,23(12).
[18]Marin A,Garcia Diez A,Fernandez Herrera J,etc.Life-threatening graft-vs-host disease.[J].2005,23(3).
[19]Katarina, Le Blanc,Ida, Rasmusson,Berit, Sundberg,etc.Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.[J].2004,363.
[20]Selvaag E,Jacobsen N,Thomsen K.Facial premature ageing as a side-effect following bone marrow transplantation.[J].2003,17(5).